For: | Ustundag Y, Bronk SF, Gores GJ. Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells. World J Gastroenterol 2007; 13(6): 851-857 [PMID: 17352013 DOI: 10.3748/wjg.v13.i6.851] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i6/851.htm |
Number | Citing Articles |
1 |
Marcus Wiedmann, Helmut Witzigmann, Joachim Mössner. Clinical Hepatology. 2010; : 1519 doi: 10.1007/978-3-642-04519-6_62
|
2 |
Gu Jing, Kaiyu Yuan, Qiuli Liang, Yong Sun, Xia Mao, Jay M McDonald, Yabing Chen. Reduced CaM/FLIP binding by a single point mutation in c-FLIPL modulates Fas-mediated apoptosis and decreases tumorigenesis. Laboratory Investigation 2012; 92(1): 82 doi: 10.1038/labinvest.2011.131
|
3 |
Kulthida Vaeteewoottacharn, Ryusho Kariya, Kouki Matsuda, Manabu Taura, Chaisiri Wongkham, Sopit Wongkham, Seiji Okada. Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma. Journal of Cancer Research and Clinical Oncology 2013; 139(9): 1551 doi: 10.1007/s00432-013-1473-6
|
4 |
Saverio Tardito, Claudio Isella, Enzo Medico, Luciano Marchiò, Elena Bevilacqua, Maria Hatzoglou, Ovidio Bussolati, Renata Franchi-Gazzola. The Thioxotriazole Copper(II) Complex A0 Induces Endoplasmic Reticulum Stress and Paraptotic Death in Human Cancer Cells. Journal of Biological Chemistry 2009; 284(36): 24306 doi: 10.1074/jbc.M109.026583
|
5 |
Tadashi Uwagawa, Katsuhiko Yanaga. Effect of NF-κB inhibition on chemoresistance in biliary–pancreatic cancer. Surgery Today 2015; 45(12): 1481 doi: 10.1007/s00595-015-1129-z
|
6 |
Xiaoqian Zou, Fei Meng, Chengyu Fu, Jieying Zhou, Yi Zhang, Ruixuan Wang, Chengwan Zhang, Zhiyu Li, Qinglong Guo, Lin Yang. LZ-106, a potent lysosomotropic agent, causing TFEB-dependent cytoplasmic vacuolization. Gene 2020; 760: 145017 doi: 10.1016/j.gene.2020.145017
|
7 |
Lin Han, Bingbing Zhu, Hui Chen, Yuanmeng Jin, Jian Liu, Weiming Wang. Proteasome inhibitor MG132 inhibits the process of renal interstitial fibrosis. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7329
|
8 |
Bingbing Zhu, Yuanmeng Jin, Lin Han, Hui Chen, Fang Zhong, Weiming Wang, Nan Chen. Proteasome inhibitor inhibits proliferation and induces apoptosis in renal interstitial fibroblasts. Pharmacological Reports 2013; 65(5): 1357 doi: 10.1016/S1734-1140(13)71494-4
|
9 |
Maija Pesonen, Merja Häkkinen, Kirsi Rilla, Risto Juvonen, Tapio Kuitunen, Markku Pasanen, Kirsi Vähäkangas. Chloropicrin-induced toxic responses in human lung epithelial cells. Toxicology Letters 2014; 226(2): 236 doi: 10.1016/j.toxlet.2014.02.006
|
10 |
William Ka Kei Wu, Chi Hin Cho, Chung Wa Lee, Kaichun Wu, Daiming Fan, Jun Yu, Joseph Jao Yiu Sung. Proteasome inhibition: A new therapeutic strategy to cancer treatment. Cancer Letters 2010; 293(1): 15 doi: 10.1016/j.canlet.2009.12.002
|
11 |
Hannah M. Heath-Engel, Bing Wang, Gordon C. Shore. Bcl2 at the endoplasmic reticulum protects against a Bax/Bak-independent paraptosis-like cell death pathway initiated via p20Bap31. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2012; 1823(2): 335 doi: 10.1016/j.bbamcr.2011.11.020
|
12 |
Yucel Ustundag, Yusuf Bayraktar. Cholangiocarcinoma: A compact review of the literature. World Journal of Gastroenterology 2008; 14(42): 6458-6466 doi: 10.3748/wjg.14.6458
|
13 |
Pritish Pawar, Liping Ma, Chang Hyun Byon, Hui Liu, Eun-Young Ahn, Nirag Jhala, Juan P. Arnoletti, Jay M. McDonald, Yabing Chen. Molecular Mechanisms of Tamoxifen Therapy for Cholangiocarcinoma: Role of Calmodulin. Clinical Cancer Research 2009; 15(4): 1288 doi: 10.1158/1078-0432.CCR-08-1150
|
14 |
Liliane Abodo Onambele, Natalie Hoffmann, Lisa Kater, Lars Hemmersbach, Jörg-Martin Neudörfl, Nikolay Sitnikov, Benjamin Kater, Corazon Frias, Hans-Günther Schmalz, Aram Prokop. An organometallic analogue of combretastatin A-4 and its apoptosis-inducing effects on lymphoma, leukemia and other tumor cells in vitro. RSC Medicinal Chemistry 2022; 13(9): 1044 doi: 10.1039/D2MD00144F
|
15 |
Dongjoo Lee, In Young Kim, Sharmistha Saha, Kyeong Sook Choi. Paraptosis in the anti-cancer arsenal of natural products. Pharmacology & Therapeutics 2016; 162: 120 doi: 10.1016/j.pharmthera.2016.01.003
|
16 |
Florian Eckel, Roland M Schmid. Emerging drugs for biliary cancer. Expert Opinion on Emerging Drugs 2007; 12(4): 571 doi: 10.1517/14728214.12.4.571
|
17 |
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Targeted medical therapy of biliary tract cancer: Recent advances and future perspectives. World Journal of Gastroenterology 2008; 14(46): 7021-7032 doi: 10.3748/wjg.14.7021
|
18 |
Mi Jin Yoon, A Reum Lee, Soo Ah Jeong, You-Sun Kim, Jin Yeop Kim, Yong-Jun Kwon, Kyeong Sook Choi. Release of Ca2+ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells. Oncotarget 2014; 5(16): 6816 doi: 10.18632/oncotarget.2256
|
19 |
Kai-Jian Chu, Yu-Shui Ma, Xiao-Hui Jiang, Ting-Miao Wu, Zhi-Jun Wu, Zhi-Zhen Li, Jing-Han Wang, Qing-Xiang Gao, Bin Yi, Yi Shi, Hui-Min Wang, Li-Peng Gu, Su-Qing Zhang, Gao-Ren Wang, Ji-Bin Liu, Da Fu, Xiao-Qing Jiang. Whole-Transcriptome Sequencing Identifies Key Differentially Expressed mRNAs, miRNAs, lncRNAs, and circRNAs Associated with CHOL. Molecular Therapy - Nucleic Acids 2020; 21: 592 doi: 10.1016/j.omtn.2020.06.025
|
20 |
Victoria Cavaliere, Daniela L. Papademetrio, Tomás Lombardo, Susana N. Costantino, Guillermo A. Blanco, Elida M. C. Álvarez. Caffeic acid phenylethyl ester and MG132, two novel nonconventional chemotherapeutic agents, induce apoptosis of human leukemic cells by disrupting mitochondrial function. Targeted Oncology 2014; 9(1): 25 doi: 10.1007/s11523-013-0256-y
|
21 |
Gu Jing, Kaiyu Yuan, Amy N Turk, Nirag C Jhala, Juan P Arnoletti, Kui Zhang, Jay M McDonald, Yabing Chen. Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis. Laboratory Investigation 2011; 91(6): 896 doi: 10.1038/labinvest.2011.60
|
22 |
Weiping Zhu, Dihua Zhan, Lu Wang, Dening Ma, Mingrong Cheng, Huipeng Wang, Jiaying Zhao, Yuankun Cai, Zhijian Cheng. Proteasome inhibitor MG132 potentiates TRAIL-induced apoptosis in gallbladder carcinoma GBC-SD cells via DR5-dependent pathway. Oncology Reports 2016; 36(2): 845 doi: 10.3892/or.2016.4839
|
23 |
Giuseppe Tonini, Vladimir Virzì, Maria Elisabetta Fratto, Bruno Vincenzi, Daniele Santini. Targeted Therapy in Biliary Tract Cancer: 2009 Update. Future Oncology 2009; 5(10): 1675 doi: 10.2217/fon.09.130
|
24 |
Crystal S. Denlinger, Neal J. Meropol, Tianyu Li, Nancy L. Lewis, Paul F. Engstrom, Louis M. Weiner, Jonathan D. Cheng, R. Katherine Alpaugh, Harry Cooper, John J. Wright, Steven J. Cohen. A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers. Clinical Colorectal Cancer 2014; 13(2): 81 doi: 10.1016/j.clcc.2013.12.005
|
25 |
Valentina Gandin, Maura Pellei, Francesco Tisato, Marina Porchia, Carlo Santini, Cristina Marzano. A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling. Journal of Cellular and Molecular Medicine 2012; 16(1): 142 doi: 10.1111/j.1582-4934.2011.01292.x
|
26 |
Lei Wang, Yang Yu, Dar-Chone Chow, Fei Yan, Chih-Chao Hsu, Fabio Stossi, Michael A. Mancini, Timothy Palzkill, Lan Liao, Suoling Zhou, Jianming Xu, David M. Lonard, Bert W. O’Malley. Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death. Cancer Cell 2015; 28(2): 240 doi: 10.1016/j.ccell.2015.07.005
|
27 |
Toshihiko Aki, Akina Nara, Koichi Uemura. Cytoplasmic vacuolization during exposure to drugs and other substances. Cell Biology and Toxicology 2012; 28(3): 125 doi: 10.1007/s10565-012-9212-3
|